{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for mycophenolic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:perenostobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03860038: Phase 2 Interventional Active, not recruiting Multiple Myeloma in Relapse
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:gresonitamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pradusinstobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lipustobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sacituzumab tirumotecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:cenzestotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
